SELARL PHARMACIE ZAZOUN : revenue, balance sheet and financial ratios

SELARL PHARMACIE ZAZOUN is a French company founded 18 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in PARIS (75004), this company of category PME shows in 2019 a revenue of 1.1 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-04-18

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - SELARL PHARMACIE ZAZOUN (SIREN 503064206)
Indicator 2021 2019 2018 2017 2016 2015
Revenue N/C 1 142 034 € 1 441 914 € 1 552 851 € 1 361 470 € 1 271 849 €
Net income 13 396 € 42 834 € 87 223 € 153 475 € 127 497 € 82 136 €
EBITDA N/C 81 454 € 122 123 € 197 721 € 154 070 € 132 013 €
Net margin N/C 3.8% 6.0% 9.9% 9.4% 6.5%

Revenue and income statement

In 2021, SELARL PHARMACIE ZAZOUN generates positive net income of 13 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2015-2021: 82 k€ -> 13 k€.

Net income (2021) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

13 396 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 1020%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 6%. Low autonomy: the company heavily depends on external financing (banks, suppliers).

Debt ratio (2021) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

1019.541%

Financial autonomy (2021) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

5.961%

Asset age ratio (2021) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

49.7%

Solvency indicators evolution
SELARL PHARMACIE ZAZOUN

Sector positioning

Debt ratio
1019.54 2021
2018
2019
2021
Q1: 29.03
Med: 85.52
Q3: 208.44
Watch

In 2021, the debt ratio of SELARL PHARMACIE ZAZOUN (1019.54) ranks in the top 25% of the sector. This ratio measures the weight of debt relative to equity. A high ratio may indicate excessive dependence on external financing.

Financial autonomy
5.96% 2021
2018
2019
2021
Q1: 25.89%
Med: 44.41%
Q3: 64.18%
Watch

In 2021, the financial autonomy of SELARL PHARMACIE ZAZOUN (6.0%) ranks in the bottom 25% of the sector. This ratio represents the share of equity in total financing. Low autonomy may limit investment capacity and increase vulnerability.

Repayment capacity
9.28 years 2019
2018
2019
Q1: 1.73 years
Med: 5.0 years
Q3: 9.48 years
Average +35 pts over 2 years

In 2019, the repayment capacity of SELARL PHARMACIE ZAZOUN (9.28) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 119.61. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2021) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

119.605

Liquidity indicators evolution
SELARL PHARMACIE ZAZOUN

Sector positioning

Liquidity ratio
119.61 2021
2018
2019
2021
Q1: 139.2
Med: 190.68
Q3: 259.62
Watch +11 pts over 3 years

In 2021, the liquidity ratio of SELARL PHARMACIE ZAZOUN (119.61) ranks in the bottom 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio below 1 may signal potential cash flow tensions.

Interest coverage
25.92x 2019
2018
2019
Q1: 1.36x
Med: 5.41x
Q3: 11.35x
Excellent

In 2019, the interest coverage of SELARL PHARMACIE ZAZOUN (25.9x) ranks in the top 25% of the sector. This ratio indicates how many times operating income covers interest expenses. High coverage means financial charges weigh little on profitability.

Working capital requirement (WCR) and payment terms

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 713 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 3045 days. Excellent situation: suppliers finance 2332 days of the operating cycle (retail model).

Operating WCR (2021) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

0 €

Customer credit (2021) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

713 j

Supplier credit (2021) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

3045 j

Inventory turnover (2021) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

0 j

WCR and payment terms evolution
SELARL PHARMACIE ZAZOUN

Positioning of SELARL PHARMACIE ZAZOUN in its sector

Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Valuation estimate

Based on 220 transactions of similar company sales in 2021, the value of SELARL PHARMACIE ZAZOUN is estimated at 153 657 € (range 98 802€ - 237 352€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2021
220 transactions
98k€ 153k€ 237k€
153 657 € Range: 98 802€ - 237 352€
NAF 5 année 2021

Valuation method used

Net Income Multiple
13 396 € × 11.5x = 153 658 €
Range: 98 803€ - 237 353€

Only this financial indicator is available for this company.

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 220 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare SELARL PHARMACIE ZAZOUN with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de détail de produits pharmaceutiques en magasin spécialisé

Frequently asked questions about SELARL PHARMACIE ZAZOUN

What is the revenue of SELARL PHARMACIE ZAZOUN ?

The revenue of SELARL PHARMACIE ZAZOUN in 2019 is 1.1 M€.

Is SELARL PHARMACIE ZAZOUN profitable?

Yes, SELARL PHARMACIE ZAZOUN generated a net profit of 13 k€ in 2021.

Where is the headquarters of SELARL PHARMACIE ZAZOUN ?

The headquarters of SELARL PHARMACIE ZAZOUN is located in PARIS (75004), in the department Paris.

Where to find the tax return of SELARL PHARMACIE ZAZOUN ?

The tax return of SELARL PHARMACIE ZAZOUN is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does SELARL PHARMACIE ZAZOUN operate?

SELARL PHARMACIE ZAZOUN operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.